{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:29:23Z","timestamp":1790630963777,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AAPS J"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1208\/aapsj070489","type":"journal-article","created":{"date-parts":[[2006,4,7]],"date-time":"2006-04-07T20:11:23Z","timestamp":1144440683000},"page":"E914-E921","source":"Crossref","is-referenced-by-count":50,"title":["Role of animal models in the study of drug-induced hypersensitivity reactions"],"prefix":"10.1208","volume":"7","author":[{"given":"Jack","family":"Uetrecht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"74914_CR1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1021\/tx980249i","volume":"12","author":"JP Uetrecht","year":"1999","unstructured":"Uetrecht JP. New concepts in immunology relevant to idiosyncratic drug reactions: the \u201cdanger hypothesis\u201d and innate immune system.Chem Res Toxicol. 1999;12:387\u2013395","journal-title":"Chem Res Toxicol."},{"key":"74914_CR2","first-page":"149","volume":"9","author":"SR Knowles","year":"2002","unstructured":"Knowles SR, Uetrecht JP, Shear NH. Confirming false adverse reactions to drugs by performing individualized, randomized trials.Can J Clin Pharmacol. 2002;9:149\u2013153.","journal-title":"Can J Clin Pharmacol."},{"key":"74914_CR3","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.iac.2004.03.002","volume":"24","author":"E Macy","year":"2004","unstructured":"Macy E. Multiple antibiotic allegry syndrome.Immunol Allergy Clin North Am. 2004;24:533\u2013543.","journal-title":"Immunol Allergy Clin North Am."},{"key":"74914_CR4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/BF01857095","volume":"4","author":"IA Jaffe","year":"1981","unstructured":"Jaffe IA. Induction of auto-immune syndromes by penicillamine therapy in rheumatoid arthritis and other diseases.Springer Semin Immunopathol. 1981;4:193\u2013207.","journal-title":"Springer Semin Immunopathol."},{"key":"74914_CR5","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/0002-9343(78)90186-9","volume":"64","author":"AS Weiss","year":"1978","unstructured":"Weiss AS, Markenson JA, Weiss MS, Kammerer WH. Toxicity of D-penicillamine in rheumatoid arthritis: a report of 63 patients including 2 with aplastic anemia and one with the nephrotic syndrome.Am J Med. 1978;64:114\u2013120.","journal-title":"Am J Med."},{"key":"74914_CR6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.7326\/0003-4819-92-1-24","volume":"92","author":"HB Stein","year":"1980","unstructured":"Stein HB, Patterson AC, Offer RC, Atkins CJ, Teufel A, Robinson HS. Adverse effects of D-penicillamine in rheumatoid arthritis.Ann Intern Med. 1980;92:24\u201329.","journal-title":"Ann Intern Med."},{"key":"74914_CR7","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/0090-1229(84)90015-1","volume":"30","author":"AJ Donker","year":"1984","unstructured":"Donker AJ, Venuto RC, Vladutiu AO, Brentjens JR, Andres GA. Effects of prolonged administration of D-penicillamine or captopril in various strains of rats.Clin Immunol Immunopathol. 1984;30:142\u2013155.","journal-title":"Clin Immunol Immunopathol."},{"key":"74914_CR8","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.4049\/jimmunol.144.8.2985","volume":"144","author":"H Tournade","year":"1990","unstructured":"Tournade H, Pelletier L, Pasquier R, Vial M, Mandet C, Druet P. D-Penicillamine-induced autoimmunity in Brown-Norway rats: similarities with HgCl2-induced autoimmunity.J Immunol. 1990;144:2985\u20132991.","journal-title":"J Immunol."},{"key":"74914_CR9","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1021\/tx034195a","volume":"17","author":"MJ Masson","year":"2004","unstructured":"Masson MJ, Uetrecht JP. Tolerance induced by low dose D-penicillamine in the Brown Norway rat model of drug-induced autoimmunity is immune-mediated.Chem Res Toxicol. 2004;17:82\u201394.","journal-title":"Chem Res Toxicol."},{"key":"74914_CR10","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1021\/tx0498399","volume":"17","author":"B Seguin","year":"2004","unstructured":"Seguin B, Masson MJ, Uetrecht J. D-penicillamine-induced autoimmunity in the Brown Norway rat: role for both T and non-T splenocytes in adoptive transfer of tolerance.Chem Res Toxicol. 2004;17:1299\u20131302.","journal-title":"Chem Res Toxicol."},{"key":"74914_CR11","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0300-483X(01)00385-7","volume":"163","author":"E Sayeh","year":"2001","unstructured":"Sayeh E, Uetrecht JP. Factors that modify penicillamine-induced autoimmunity in Brown Norway rats: failure of the Th1\/Th2 paradigm.Toxicology, 2001;163:195\u2013211.","journal-title":"Toxicology"},{"key":"74914_CR12","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1021\/tx050040m","volume":"18","author":"B Seguin","year":"2005","unstructured":"Seguin B, Boutros PC, Li X, Okey AB, Uetrecht JP. Gene expression profiling in a model of d-penicillamine-induced autoimmunity in the Brown Norway rat: predictive value of early signs of danger.Chem Res Toxicol. 2005;18:1193\u20131202.","journal-title":"Chem Res Toxicol."},{"key":"74914_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/15476910490496258","volume":"1","author":"MJ Masson","year":"2004","unstructured":"Masson MJ, Teranishi M, Shenton JM, Uetrecht JP. Investigation of the involvement of macrophages and T cells in D-penicillamine-induced autoimmunity in the Brown Norway rat.J Immunotoxicol. 2004;1:79\u201393.","journal-title":"J Immunotoxicol."},{"key":"74914_CR14","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.4049\/jimmunol.143.5.1482","volume":"143","author":"J Rhodes","year":"1989","unstructured":"Rhodes J. Evidence for an intercellular covalent reaction essential in antigen-specific T cell activation.J Immunol. 1989;143:1482\u20131489.","journal-title":"J Immunol."},{"key":"74914_CR15","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.autrev.2005.01.002","volume":"4","author":"J Uetrecht","year":"2005","unstructured":"Uetrecht J. Current trends in drug-induced autoimmunity.Autoimmun Rev. 2005:4:309\u2013314.","journal-title":"Autoimmun Rev."},{"key":"74914_CR16","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1086\/317536","volume":"32","author":"SJ Bersoff-Matcha","year":"2001","unstructured":"Bersoff-Matcha SJ, Miller WC, Aberg JA, et al. Sex differences in nevirapine rash.Clin Infect Dis. 2001;32:124\u2013129.","journal-title":"Clin Infect Dis."},{"key":"74914_CR17","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1021\/tx034064+","volume":"16","author":"JM Shenton","year":"2003","unstructured":"Shenton JM, Teranishi M, Abu-Asab MS, Yager JA, Uetrecht JP. Characterization of a potential animal model of an idiosyncratic drug reaction: nevirapine-induced skin rash in the rat.Chem Res Toxicol. 2003;16:1078\u20131089.","journal-title":"Chem Res Toxicol."},{"key":"74914_CR18","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1021\/tx0501132","volume":"18","author":"JM Shenton","year":"2005","unstructured":"Shenton JM, Popovic M, Chen J, Masson MJ, Uetrecht JP. Evidence of an immune-mediated mechanism for an idiosyncratic nevirapine-induced reaction in the female brown norway ratChem Res Toxicol. 2005;18:1799\u20131813.","journal-title":"Chem Res Toxicol."},{"key":"74914_CR19","first-page":"13","volume":"234","author":"DP Aucoin","year":"1985","unstructured":"Aucoin DP, Peterson ME, Hurvitz AI, et al. Propylthiouracil-induced immune-mediated disease in the cat.J Pharmacol Exp Ther. 1985;234:13\u201318.","journal-title":"J Pharmacol Exp Ther."},{"key":"74914_CR20","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1002\/art.1780310517","volume":"31","author":"DP Aucoin","year":"1988","unstructured":"Aucoin DP, Rubin RL, Peterson ME, et al. Dose-dependent induction of antinative DNA antibodies in cats by propylthiouracil.Arthritis Rheum. 1988;31:688\u2013692.","journal-title":"Arthritis Rheum."},{"key":"74914_CR21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0300-483X(96)03476-2","volume":"114","author":"L Waldhauser","year":"1996","unstructured":"Waldhauser L, Uetrecht J. Antibodies to myeloperoxidase in propylthiouracil-induced autoimmune disease in the cat.Toxicology. 1996;114:155\u2013162.","journal-title":"Toxicology"},{"key":"74914_CR22","first-page":"354","volume":"19","author":"L Waldhauser","year":"1991","unstructured":"Waldhauser L, Uetrecht J. Oxidation of propylthiouracil to reactive metabolites by activated neutrophils: implications for agranulocytosis.Drug Metab Dispos. 1991;19:354\u2013359.","journal-title":"Drug Metab Dispos."},{"key":"74914_CR23","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/S0049-0172(99)80004-3","volume":"28","author":"O Elkayam","year":"1999","unstructured":"Elkayam O, Yaron M, Caspi D. Minocycline-induced autoimmune syndromes: an overview.Semin Arthritis Rheum. 1999;28:392\u2013397.","journal-title":"Semin Arthritis Rheum."},{"key":"74914_CR24","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/j.1365-2249.1990.tb05342.x","volume":"81","author":"L N\u00e4ssberger","year":"1990","unstructured":"N\u00e4ssberger L, Sj\u00f6holm AG, Jonsson H, Sturfelt G, \u00c5kesson A. Autoantibodies against neutrophil cytoplasm components in systemic lupus erythematosus and in hydralazine-induced lupus.Clin Exp Immunol. 1990;81:380\u2013383.","journal-title":"Clin Exp Immunol."},{"key":"74914_CR25","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1365-2885.2004.00576.x","volume":"27","author":"LA Trepanier","year":"2004","unstructured":"Trepanier LA. Idiosyncratic toxicity associated with potentiated sulfonamides in the dog.J Vet Pharmacol Ther. 2004;27:129\u2013138.","journal-title":"J Vet Pharmacol Ther."},{"key":"74914_CR26","volume-title":"Hepatotoxicity: The Adverse Effects of Drugs and Other Chemicals on the Liver","author":"H Zimmerman","year":"1999","unstructured":"Zimmerman H.Hepatotoxicity: The Adverse Effects of Drugs and Other Chemicals on the Liver; Philadelphia, PA: Lippincott Williams & Wilkins. 1999."},{"key":"74914_CR27","first-page":"733","volume":"242","author":"JG Kenna","year":"1987","unstructured":"Kenna JG, Neuberger J, Williams R. Identification by immunoblotting of 3 halothane-induced liver microsomal polypeptide antigens recognized by antibodies in sera from patients with halothane-associated hepatitis.J Pharmacol Exp Ther. 1987;242:733\u2013740.","journal-title":"J Pharmacol Exp Ther."},{"key":"74914_CR28","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1073\/pnas.86.1.322","volume":"86","author":"H Satoh","year":"1989","unstructured":"Satoh H, Martin BM, Schulick AH, Christ DD, Kenna JG, Pohl LR. Human anti-endoplasmic reticulum antibodies in sera of patients with halothane-induced hepatitis are directed against a trifluoroacetylated carboxylesterase.Proc Natl Acad Sci USA. 1989;86:322\u2013326.","journal-title":"Proc Natl Acad Sci USA."},{"key":"74914_CR29","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1021\/tx960083q","volume":"9","author":"M Bourdi","year":"1996","unstructured":"Bourdi M, Chen W, Peter RM, et al. Human cytochrome P450 2E1 is a major autoantigen associated with halothane hepatitis.Chem Res Toxicol. 1996;9:1159\u20131166.","journal-title":"Chem Res Toxicol."},{"key":"74914_CR30","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/00000542-197910000-00008","volume":"51","author":"GE McLain","year":"1979","unstructured":"McLain GE, Sipes IG, Brown BR. An animal model of halothane hepatotoxicity: roles of enzyme induction and hypoxia.Anesthesiology 1979;51:321\u2013326.","journal-title":"Anesthesiology"},{"key":"74914_CR31","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1006\/taap.1996.8093","volume":"143","author":"SM Furst","year":"1997","unstructured":"Furst SM, Luedke D, Gaw HH, Reich R, Gandolfi AJ. Demonstration of a cellular immune response in halothane-exposed guinea pigs.Toxicol Appl Pharmacol. 1997;143:245\u2013255.","journal-title":"Toxicol Appl Pharmacol."},{"key":"74914_CR32","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/0006-2952(88)90733-2","volume":"37","author":"JL Maggs","year":"1988","unstructured":"Maggs JL, Tingle MD, Kitteringham NR, Park BK. Drug-protein conjugates-XIV: mechanisms of formation of protein-arylating intermediates from amodiaquine, a myelotoxin, and hepatoxin in man.Biochem Pharmacol. 1988;37:303\u2013311.","journal-title":"Biochem Pharmacol."},{"key":"74914_CR33","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1159\/000235475","volume":"95","author":"JB Clarke","year":"1991","unstructured":"Clarke JB, Neftel K, Kitteringham NR, Park BK. Detection of antidrug IgG antibodies in patients with adverse drug reactions to amodiaquine.IntArch Allergy Appl Immunol. 1991;95:369\u2013375.","journal-title":"IntArch Allergy Appl Immunol."},{"key":"74914_CR34","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1159\/000235138","volume":"91","author":"JB Clarke","year":"1990","unstructured":"Clarke JB, Maggs JL, Kitteringham NR, Park BK. Immunogenicity of amodiaquine in the rat.Int Arch Allergy Appl Immunol. 1990;91:335\u2013342.","journal-title":"Int Arch Allergy Appl Immunol."},{"key":"74914_CR35","first-page":"364","volume":"213","author":"JA Timbrell","year":"1980","unstructured":"Timbrell JA, Mitchell JR, Snodgrass WR, Nelson SD. Isoniazid hepatotoxicity: the relationship between covalent binding and metabolism in vivo.J Pharmacol Exp Ther. 1980;213:364\u2013369.","journal-title":"J Pharmacol Exp Ther."},{"key":"74914_CR36","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/1056-8719(95)00044-I","volume":"34","author":"TC Sarich","year":"1995","unstructured":"Sarich TC, Zhou T, Adams SP, Bain AI, Wall RA, Wright JM. A model of isoniazid-induced hepatotoxicity in rabbits.J Pharmacol Toxicol Methods. 1995;34:109\u2013116.","journal-title":"J Pharmacol Toxicol Methods."},{"key":"74914_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1124\/jpet.103.054288","volume":"307","author":"JP Luyendyk","year":"2003","unstructured":"Luyendyk JP, Maddox JF, Cosma GN, Ganey PE, Cockerell GL, Roth RA. Ranitidine treatment during a modest inflammatory response precipitates idioxyncrasy-like liver injury in rats.J Pharmacol Exp Ther. 2003;307:9\u201316.","journal-title":"J Pharmacol Exp Ther."},{"key":"74914_CR38","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1124\/jpet.105.087981","volume":"314","author":"JP Luyendyk","year":"2005","unstructured":"Luyendyk JP, Shaw PJ, Green CD, Maddox JF, Ganey PE, Roth RA. Coagulation-mediated hypoxia and neutrophil-dependent hepatic injury in rats given lipopolysaccharide and ranitidine.J Pharmacol Exp Ther. 2005:314:1023\u20131031.","journal-title":"J Pharmacol Exp Ther."},{"key":"74914_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/jpet.102.041624","volume":"307","author":"RA Roth","year":"2003","unstructured":"Roth RA, Luyendyk JP, Maddox JF, Ganey PE. Inflammation and drug idiosyncrasy: is there a connection?,J Pharmacol Exp Ther. 2003;307:1\u20138.","journal-title":"J Pharmacol Exp Ther."},{"key":"74914_CR40","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0378-4274(01)00487-8","volume":"127","author":"R Pieters","year":"2002","unstructured":"Pieters R, Ezendam J, Bleumink R, Bol M, Nierkens S. Predictive testing for autoimmunity.Toxicol Lett. 2002;127:83\u201391.","journal-title":"Toxicol Lett."},{"key":"74914_CR41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1021\/tx034170b","volume":"17","author":"DC Evans","year":"2004","unstructured":"Evans DC, Watt AP, Nicoll-Griffith DA, Baillie TA. Drug-protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development.Chem Res Toxicol. 2004;17:3\u201316.","journal-title":"Chem Res Toxicol."},{"key":"74914_CR42","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3109\/10408449509049338","volume":"25","author":"N Bloksma","year":"1995","unstructured":"Bloksma N, Kubicka-Muranyi M, Schuppe H, Gleichmann E, Gleichmann H. Predictive immunotoxicological test systems: suitability of the popliteal lymph node assay in mice and rats.Crit Rev Toxicol. 1995;25:369\u2013396.","journal-title":"Crit Rev Toxicol."},{"key":"74914_CR43","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/toxsci\/51.1.71","volume":"51","author":"BW Gutting","year":"1999","unstructured":"Gutting BW, Schomaker SJ, Kaplan AH, Amache DE. A comparison of the direct and reporter antigen popliteal lymph node assay for the detection of immunomodulation by low molecular weight compounds.Toxicol Sci. 1999;51:71\u201379.","journal-title":"Toxicol Sci."},{"key":"74914_CR44","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1093\/toxsci\/kfh074","volume":"79","author":"S Nierkens","year":"2004","unstructured":"Nierkens S, Nieuwenhuijsen L, Thomas M, Pieters R. Evaluation of the use of reporter antigens in an auricular lymph node assay to assess the immunosensitizing potential of drugs.Toxicol Sci. 2004:79:90\u201397.","journal-title":"Toxicol Sci."},{"key":"74914_CR45","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1124\/jpet.105.086009","volume":"314","author":"S Roychowdhury","year":"2005","unstructured":"Roychowdhury S, Vyas PM, Reilly TP, Gaspari AA, Svensson CK, Characterization of the formation and localization of sulfamethoxazole and dapsone-associated drug-protein adducts in human epidermal keratinocytes.J Pharmacol Exp Ther. 2005;314:43\u201352.","journal-title":"J Pharmacol Exp Ther."},{"key":"74914_CR46","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/0192-0561(88)90047-1","volume":"10","author":"ME Kammueller","year":"1988","unstructured":"Kammueller ME, Seinen W. Structural requirements for hydantoins and 2-thiohydantoins to induce lymphoproliferative popliteal lymph node reactions in the mouse.Int J Immunopharmacol. 1988;10:997\u20131010.","journal-title":"Int J Immunopharmacol."},{"key":"74914_CR47","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nri1372","volume":"4","author":"SY Seong","year":"2004","unstructured":"Seong SY, Matzinger P. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses.Nat Rev Immunol. 2004;4:469\u2013478.","journal-title":"Nat Rev Immunol."},{"key":"74914_CR48","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/0008-8749(91)90150-A","volume":"138","author":"PH Wooley","year":"1991","unstructured":"Wooley PH, Whalen JD. Pristane-induced arthritis in mice. III. Lymphocyte phenotypic and functional abnormalities precede the development of pristane-induced arthritis.Cell Immunol. 1991;138:251\u2013259.","journal-title":"Cell Immunol."},{"key":"74914_CR49","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1006\/taap.1996.8078","volume":"143","author":"R Albers","year":"1997","unstructured":"Albers R, Broeders A, van der Pijl A, Seinen W, Pieters R. The use of reporter antigens in the popliteal lymph node assay to assess immunomodulation by chemicals.Toxicol Appl Pharmacol. 1997;143:102\u2013109.","journal-title":"Toxicol Appl Pharmacol."},{"key":"74914_CR50","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/toxsci\/kfi021","volume":"83","author":"S Nierkens","year":"2005","unstructured":"Nierkens S, Aalbers M, Bol M, van Wijk F, Hassing I, Pieters R. Development of an oral exposure mouse model to predict drug-induced hypersensitivity reactions by using reporter antigens.Toxicol Sci. 2005;83:273\u2013281.","journal-title":"Toxicol Sci."}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/aapsj070489.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/aapsj070489\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/aapsj070489.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/aapsj070489","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T08:38:32Z","timestamp":1736325512000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/aapsj070489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["74914"],"URL":"https:\/\/doi.org\/10.1208\/aapsj070489","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}